Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahalingam

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The British Journal of Dermatology|November 19, 2009
BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naeviL P Nguyen, A Emley, N Wajapeyee, et al.
Bioconjugate Chemistry|September 7, 2018
Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic TumorsSakkarapalayam M Mahalingam, Haiyan Chu, Xin Liu, et al.
Clinical Immunology and Immunopathology|November 1, 1996
Abnormalities of CD45 isoform expression in HIV infectionM Mahalingam, A Pozniak, T J McManus, et al.
The British Journal of Dermatology|October 24, 2008
RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesisO E Dadzie, S Yang, A Emley, et al.
Clinical and Experimental Dermatology|May 3, 2012
Pagetoid reticulosis in a prepubescent boy successfully treated with photodynamic therapyG W Mendese, A Beckford, N Krejci, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Markers of immune cell activation and disease progression. Cell activation in HIV diseaseM Peakman, M Mahalingam, A Pozniak, et al.
Tetrahedron Letters|April 10, 2010
Design and Synthesis of Potential New Apoptosis Agents: Hybrid Compounds Containing Perillyl Alcohol and New Constrained RetinoidsBhaskar C Das, Sakkarapalayam M Mahalingam, Lipsa Panda, et al.
Clinical and Experimental Immunology|September 1, 1993
T cell activation and disease severity in HIV infectionM Mahalingam, M Peakman, E T Davies, et al.
Chemical Communications (Cambridge, England)|April 11, 2009
Design and synthesis of (E)-1-((3-ethyl-2,4,4-trimethylcyclohex-2-enylidene)methyl-4-substituted benzenes from 1-(2,6,6-trimethylcyclohex-1-enyl)ethanolBhaskar C Das, Sakkarapalayam M Mahalingam, Todd Evans, et al.
Tetrahedron Letters|September 28, 2011
Synthesis of function-oriented 2-phenyl-2H-chromene derivatives using L-pipecolinic acid and substituted guanidine organocatalystsBhaskar C Das, Seetaram Mohapatra, Philip D Campbell, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The British Journal of Dermatology|November 19, 2009
BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naeviL P Nguyen, A Emley, N Wajapeyee, et al.
Bioconjugate Chemistry|September 7, 2018
Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic TumorsSakkarapalayam M Mahalingam, Haiyan Chu, Xin Liu, et al.
Clinical Immunology and Immunopathology|November 1, 1996
Abnormalities of CD45 isoform expression in HIV infectionM Mahalingam, A Pozniak, T J McManus, et al.
The British Journal of Dermatology|October 24, 2008
RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesisO E Dadzie, S Yang, A Emley, et al.
Clinical and Experimental Dermatology|May 3, 2012
Pagetoid reticulosis in a prepubescent boy successfully treated with photodynamic therapyG W Mendese, A Beckford, N Krejci, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Markers of immune cell activation and disease progression. Cell activation in HIV diseaseM Peakman, M Mahalingam, A Pozniak, et al.
Tetrahedron Letters|April 10, 2010
Design and Synthesis of Potential New Apoptosis Agents: Hybrid Compounds Containing Perillyl Alcohol and New Constrained RetinoidsBhaskar C Das, Sakkarapalayam M Mahalingam, Lipsa Panda, et al.
Clinical and Experimental Immunology|September 1, 1993
T cell activation and disease severity in HIV infectionM Mahalingam, M Peakman, E T Davies, et al.
Chemical Communications (Cambridge, England)|April 11, 2009
Design and synthesis of (E)-1-((3-ethyl-2,4,4-trimethylcyclohex-2-enylidene)methyl-4-substituted benzenes from 1-(2,6,6-trimethylcyclohex-1-enyl)ethanolBhaskar C Das, Sakkarapalayam M Mahalingam, Todd Evans, et al.
Tetrahedron Letters|September 28, 2011
Synthesis of function-oriented 2-phenyl-2H-chromene derivatives using L-pipecolinic acid and substituted guanidine organocatalystsBhaskar C Das, Seetaram Mohapatra, Philip D Campbell, et al.
Pageof 7